CN104922538A - 一种用于IgA肾病中药制剂及其制备方法 - Google Patents
一种用于IgA肾病中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN104922538A CN104922538A CN201510323175.0A CN201510323175A CN104922538A CN 104922538 A CN104922538 A CN 104922538A CN 201510323175 A CN201510323175 A CN 201510323175A CN 104922538 A CN104922538 A CN 104922538A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- chinese medicine
- iga nephropathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 208000010159 IgA glomerulonephritis Diseases 0.000 title claims abstract description 23
- 206010021263 IgA nephropathy Diseases 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 56
- 210000000582 semen Anatomy 0.000 claims description 24
- 241000756943 Codonopsis Species 0.000 claims description 13
- 241000628997 Flos Species 0.000 claims description 12
- 240000008669 Hedera helix Species 0.000 claims description 12
- 239000009636 Huang Qi Substances 0.000 claims description 12
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 12
- 241000005787 Cistanche Species 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 8
- 238000001802 infusion Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000001556 precipitation Methods 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 230000002421 anti-septic effect Effects 0.000 claims description 2
- 238000010009 beating Methods 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000012567 medical material Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 238000004064 recycling Methods 0.000 claims description 2
- 235000014347 soups Nutrition 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 239000000080 wetting agent Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 42
- 210000003734 kidney Anatomy 0.000 abstract description 40
- 239000008280 blood Substances 0.000 abstract description 29
- 210000004369 blood Anatomy 0.000 abstract description 28
- 210000000988 bone and bone Anatomy 0.000 abstract description 27
- 208000002193 Pain Diseases 0.000 abstract description 13
- 230000036407 pain Effects 0.000 abstract description 10
- 208000025747 Rheumatic disease Diseases 0.000 abstract description 9
- 230000000552 rheumatic effect Effects 0.000 abstract description 9
- 239000002994 raw material Substances 0.000 abstract description 4
- 230000003014 reinforcing effect Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 241000382455 Angelica sinensis Species 0.000 abstract description 3
- 241000045403 Astragalus propinquus Species 0.000 abstract description 3
- 241000007126 Codonopsis pilosula Species 0.000 abstract description 3
- 235000006533 astragalus Nutrition 0.000 abstract description 3
- 239000002574 poison Substances 0.000 abstract description 3
- 231100000614 poison Toxicity 0.000 abstract description 3
- 241000092665 Atractylodes macrocephala Species 0.000 abstract description 2
- 244000020518 Carthamus tinctorius Species 0.000 abstract description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract description 2
- 241000336291 Cistanche deserticola Species 0.000 abstract description 2
- 244000077995 Coix lacryma jobi Species 0.000 abstract description 2
- 241000759833 Cornus officinalis Species 0.000 abstract description 2
- 241000096284 Gynochthodes officinalis Species 0.000 abstract description 2
- 240000003271 Leonurus japonicus Species 0.000 abstract description 2
- 241000112528 Ligusticum striatum Species 0.000 abstract description 2
- 244000292697 Polygonum aviculare Species 0.000 abstract description 2
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract description 2
- 244000197580 Poria cocos Species 0.000 abstract description 2
- 235000008599 Poria cocos Nutrition 0.000 abstract description 2
- 244000046095 Psophocarpus tetragonolobus Species 0.000 abstract description 2
- 241000316341 Taxillus chinensis Species 0.000 abstract description 2
- 244000237330 gutta percha tree Species 0.000 abstract description 2
- 244000281702 Dioscorea villosa Species 0.000 abstract 2
- 235000004879 dioscorea Nutrition 0.000 abstract 2
- 235000005903 Dioscorea Nutrition 0.000 abstract 1
- 235000000504 Dioscorea villosa Nutrition 0.000 abstract 1
- 235000007007 Dolichos lablab Nutrition 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 238000007781 pre-processing Methods 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 33
- 210000004185 liver Anatomy 0.000 description 26
- 239000000796 flavoring agent Substances 0.000 description 24
- 235000019634 flavors Nutrition 0.000 description 24
- 210000003205 muscle Anatomy 0.000 description 19
- 230000007812 deficiency Effects 0.000 description 17
- 230000017531 blood circulation Effects 0.000 description 15
- 235000009508 confectionery Nutrition 0.000 description 15
- 230000001737 promoting effect Effects 0.000 description 15
- 238000005728 strengthening Methods 0.000 description 15
- 206010012735 Diarrhoea Diseases 0.000 description 14
- 210000001624 hip Anatomy 0.000 description 13
- 229940079593 drug Drugs 0.000 description 12
- 206010030113 Oedema Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 208000006820 Arthralgia Diseases 0.000 description 10
- 208000004880 Polyuria Diseases 0.000 description 10
- 230000009286 beneficial effect Effects 0.000 description 10
- 230000035619 diuresis Effects 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 230000006378 damage Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 210000002700 urine Anatomy 0.000 description 8
- 201000000736 Amenorrhea Diseases 0.000 description 7
- 206010001928 Amenorrhoea Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 231100000540 amenorrhea Toxicity 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 241000721047 Danaus plexippus Species 0.000 description 6
- 208000005171 Dysmenorrhea Diseases 0.000 description 6
- 206010013935 Dysmenorrhoea Diseases 0.000 description 6
- 208000019255 Menstrual disease Diseases 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 230000036528 appetite Effects 0.000 description 5
- 235000019789 appetite Nutrition 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 210000003127 knee Anatomy 0.000 description 5
- 210000000629 knee joint Anatomy 0.000 description 5
- 239000002398 materia medica Substances 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 4
- 208000009205 Tinnitus Diseases 0.000 description 4
- 208000012886 Vertigo Diseases 0.000 description 4
- 230000001605 fetal effect Effects 0.000 description 4
- 201000001881 impotence Diseases 0.000 description 4
- 230000003907 kidney function Effects 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 230000002175 menstrual effect Effects 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 231100000886 tinnitus Toxicity 0.000 description 4
- 231100000889 vertigo Toxicity 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 241000233788 Arecaceae Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010062575 Muscle contracture Diseases 0.000 description 3
- 206010067482 No adverse event Diseases 0.000 description 3
- 206010030302 Oliguria Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000005946 Xerostomia Diseases 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 208000006111 contracture Diseases 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 206010013781 dry mouth Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 208000006750 hematuria Diseases 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 239000005541 ACE inhibitor Substances 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 description 2
- 101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 2
- 244000192528 Chrysanthemum parthenium Species 0.000 description 2
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 2
- 241000234272 Dioscoreaceae Species 0.000 description 2
- 206010018364 Glomerulonephritis Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010030124 Oedema peripheral Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000000260 Warts Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 235000008384 feverfew Nutrition 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 208000021267 infertility disease Diseases 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 201000010153 skin papilloma Diseases 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 240000000031 Achyranthes bidentata Species 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000133570 Berberidaceae Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 240000004528 Catalpa ovata Species 0.000 description 1
- 235000010005 Catalpa ovata Nutrition 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 241000357628 Codonopsis pilosula subsp. tangshen Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000142975 Cornaceae Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 241000123586 Dipsacaceae Species 0.000 description 1
- 241000729170 Dipsacus asper Species 0.000 description 1
- 241001050741 Dipsacus asperoides Species 0.000 description 1
- 241000219764 Dolichos Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241001362421 Epimedium brevicornu Species 0.000 description 1
- 241000893531 Epimedium koreanum Species 0.000 description 1
- 241001660849 Epimedium pubescens Species 0.000 description 1
- 241001362411 Epimedium sagittatum Species 0.000 description 1
- 241001362415 Epimedium wushanense Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000208686 Eucommiaceae Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000022461 Glomerular disease Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000037147 Hypercalcaemia Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000244365 Ligusticum sinense Species 0.000 description 1
- 241000221040 Loranthaceae Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 241000729196 Lycopus lucidus Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 206010029155 Nephropathy toxic Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 208000028208 end stage renal disease Diseases 0.000 description 1
- 201000000523 end stage renal failure Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000002601 glomerular mesangium Anatomy 0.000 description 1
- 206010061989 glomerulosclerosis Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000000148 hypercalcaemia Effects 0.000 description 1
- 208000030915 hypercalcemia disease Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 210000003584 mesangial cell Anatomy 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000007694 nephrotoxicity Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000008492 tangshen Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于IgA肾病的中药制剂,它是以黄芪、党参、熟地黄、炒白术、茯苓、山药、薏苡仁、白扁豆、枸杞子、山茱萸、肉苁蓉、巴戟天、杜仲、续断、桑寄生、淫羊藿、泽兰、益母草、萹蓄、萆薢、川芎、牛膝、当归、红花为原料,属于中药发明领域。根据每味中药的不同特性,以洗净切块预处理后,按比例配制,经特殊方法制作,具有补肾强骨、益精填髓、祛风利湿、活血补血作用,本发明产品组合及制作方法独特,经临床验证,该药治疗效果显著,治疗周期短,价格低廉,无不良反应和任何毒副作用,具有广阔的市场应用前景。
Description
技术领域
本发明涉及一种中药制剂,具体涉及一种用于IgA肾病中药制剂,本发明还涉及该中药制剂的制备方法。
背景技术
IgA 肾病是一组不伴有系统性疾病,肾活检免疫病理检查在肾小球系膜区有以IgA 为主的颗粒样沉积,同时伴有系膜细胞增殖、基质增生,临床上以血尿、蛋白尿为主要表现的肾小球肾炎。本病是临床常见的、慢性进展的原发性肾小球疾病,约占原发性肾小球肾炎的38% ~ 42%,约20% ~ 30% 的患者发展到终末期肾脏病。IgA 肾病的确切发病机理尚未完全清楚,多数学者认为与遗传、环境、感染、食物等多种因素有关。
IgA 肾病至今仍缺乏特异性的治疗药物。一般主张采取综合性的防治措施,如饮食的控制、积极控制高血压、避免能引起肾损害的其他因素(如感染、肾毒性的药物、高脂血症、高血糖、高钙血症、高尿酸血症等),对于蛋白尿量多的酌情选用激素或细胞毒药物。尽管血管紧张素转换酶抑制剂(ACEI)被证实有降低肾小球内压、延缓肾功能恶化、降低尿蛋白(20% ~ 40%)和减轻肾小球硬化和间质纤维化的作用,但其疗效尚未达到医生所期望的目标。
中医一般认为,本虚标实、虚实夹杂为本病的病机特点,在治疗上根据不同的分期、证型及病理分级采用辨证与辨病相结合,扶正补虚为主,并重视活血祛瘀之法。
发明内容
本发明的目的在于提供一种用于IgA肾病的中药制剂,该中药制剂对于治疗IgA肾病具有治疗效果显著,治愈时间短,价格低廉,无不良反应和副毒作用的特点。
发明人在多年的临床医疗实践中,根据该病症的发展规律,以及中药的配伍原则,并通过大量的临床验证,反复探索总结出用于治疗IgA肾病的中药制剂的新配方。本发明具有治疗效果显著,治愈时间短,价格低廉,无不良反应和副毒作用的特点。
本发明中药物的作用:
其中:
黄芪:为豆科植物蒙古黄芪 Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.)Hsiao 或膜荚黄芪 Astragalus membranaceus (Fisch.) Bge.的干燥根。性味:甘,温。归肺、脾经。功效:补气固表,利尿托毒,排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,痈疽难溃,久溃不敛,血虚痿黄,内热消渴;慢性肾炎蛋白尿,糖尿病。
党参:为桔梗科植物党参 Codonopsis pilosula (Franch.) Nannf.、素花党参(西党参)Codonopsis pilosula Nannf. var. modesta (Nannf.) L. T. Shen或川党参Codonopsis tangshen Oliv.的干燥根。性味:甘,平。归脾、肺经。功效:补中益气,健脾益肺。用于脾肺虚弱,气短心悸,食少便溏,虚喘咳嗽,内热消渴。
熟地黄:为生地黄的炮制加工品。性味:甘,微温。归肝、肾经。功能主治:滋阴补血,益精填髓。用于肝肾阴虚,腰膝酸软,骨蒸潮热,盗汗遗精,内热消渴,血虚萎黄,心悸怔忡,月经不调,崩漏下血,眩晕,耳鸣,须发早白。《珍珠囊》中记载:大补血虚不足,通血脉,益气力。
炒白术:为菊科植物白术Atractylodes macrocephala Koidz.的干燥根茎的炮制品。性味:苦、甘,温。归脾、胃经。功效:健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。土白术健脾,和胃,安胎。用于脾虚食少,泄泻便溏,胎动不安。《本经》中记载:"主风寒湿痹,死肌,痉,疸,止汗,除热消食。
茯苓:为多孔菌科真菌茯苓 Poria cocos (Schw.) Wolf 的干燥菌核。性味:甘、淡,平。归心、肺、脾、肾经。功效:利水渗湿,健脾宁心。用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。《药性论》中记载:开胃,止呕逆,善安心神。主肺痿痰壅。
山药:为薯蓣科植物薯蓣Dioscorea opposita Thunb. 的干燥根茎。性味:甘,平。归脾、肺、肾经。功效:补脾养胃,生津益肺,补肾涩精。用于脾虚食少,久泻不止,肺虚喘咳,肾虚遗精,带下,尿频,虚热消渴。麸炒山药补脾健胃。用于脾虚食少,泄泻便溏,白带过多。
薏苡仁:为禾本科植物薏苡Coix lacryma-jobi L. var. ma-yuen (Roman.)Stapf的干燥成熟种仁。性味:甘、淡,凉。归脾、胃、肺经。功效:健脾渗湿,除痹止泻,清热排浓。用于水肿,脚气,小便不利,湿痹拘挛,脾虚泄泻,肺痈,肠痈;扁平疣。《别录》中记载:除筋骨邪气不仁,利肠胃,消水肿,令人能食。
白扁豆:为豆科扁豆属植物扁豆Dolichos lablab L. 的干燥成熟种子。性味: 甘,微温。归脾、胃经。功效:健脾化湿,和中消暑。用于脾胃虚弱,食欲不振,大便溏泻,白带过多,暑湿吐泻,胸闷腹胀。
枸杞子:为茄科植物宁夏枸杞Lycium barbarum L. 的干燥成熟果实。性味:甘,平。归肝、肾经。功效:滋补肝肾,益精明目。用于虚劳精亏,腰膝酸痛,眩晕耳鸣,内热消渴,血虚萎黄,目昏不明。《食疗本草》中记载:坚筋耐老,除风,补益筋骨,能益人,去虚劳。
山茱萸:为山茱萸科植物山茱萸Cornus officinalis Sieb. et Zucc. 的干燥成熟果肉。性味:酸、涩,微温。归肝、肾经。功效:补益肝肾,涩精固脱。用于眩晕耳鸣,腰膝酸痛,阳痿遗精,遗尿尿频,崩漏带下,大汗虚脱。内热消渴。《药性论》中记载:治脑骨痛,止月水不定,补肾气;兴阳道,添精髓,疗耳鸣,除面上疮,主能发汗,止老人尿不节。
肉苁蓉:为列当科植物肉苁蓉Cistanche deserticola Y.C.Ma的干燥带鳞叶的肉质茎。性味:甘、咸,温。归肾、大肠经。功效:补肾阳,益精血,润肠通便。用于阳痿,不孕,腰膝酸软,筋骨无力,肠燥便秘。《本经》中记载:主五劳七伤,补中,除茎中寒热痛,养五脏,强阴,益精气,妇人症瘕。
巴戟天:为茜草科植物巴戟天Morinda officinalis How 的干燥根。性味:甘,辛,微温。归肾、肝经。功效:补肾阳,强筋骨,祛风湿。用于阳痿遗精,宫冷不孕,月经不调,少腹冷痛,风湿痹痛,筋骨痿软。《日华子本草》中记载:安五脏,定心气,除一切风,疗水肿。
杜仲:为杜仲科植物杜仲Eucommia ulmoides Oliv. 的干燥树皮。性味:甘,温。归肝、肾经。功效:补肝肾,强筋骨,安胎。用于肾虚腰痛,筋骨无力,妊娠漏血,胎动不安;高血压。《玉楸药解》中记载:益肝肾,养筋骨,去关节湿淫。治腰膝酸痛,腿足拘挛。
续断:为川续断科植物川续断Dipsacus asperoides C. Y. Cheng et T. M. Ai (或Dipsacus asper Wall)的干燥根。性味:苦、辛,微温。归肝、肾经。功效:补肝肾,强筋骨,续折伤,止崩漏。用于腰膝酸软,风湿痹痛,崩漏,胎漏,跌扑损伤。酒续断多用于风湿痹痛,跌扑损伤。盐续断多用于腰膝酸软。《本经》中记载:主伤寒,补不足,金疮,痈疡,折跌,续筋骨,妇人乳难,久服益气力。
桑寄生:为桑寄生科植物桑寄生Taxillus chinensis (DC.)Danser 的干燥带叶茎枝。性味:苦、甘,平。归肝、肾经。功效:补肝肾,强筋骨,祛风湿,安胎元。用于风湿痹痛,腰膝酸软,筋骨无力,崩漏经多,妊娠漏血,胎动不安;高血压。
淫羊藿:为小檗科植物淫羊藿Epimedium brevicornum Maxim.、箭叶淫羊藿Epimedium sagittatum (Sieb.et Zucc.)Maxim. 、柔毛淫羊藿Epimedium pubescens Maxim.、巫山淫羊藿Epimedium wushanense T.S.Ying、或朝鲜淫羊藿Epimedium koreanum Nakai的干燥地上部分。性味:辛、甘,温。归肝、肾经。功效:补肾阳,强筋骨,祛风湿。用于阳痿遗精,筋骨痿软,风湿痹痛,麻木拘挛;更年期高血压。《别录》:"坚筋骨。消瘰疬、赤痈;下部有疮,洗,出虫。
泽兰:为唇形科植物毛叶地瓜儿苗Lycopus lucidus Turcz. var.hirtus Regel的干燥地上部分。夏、秋季茎叶茂盛时采割,晒干。性味:苦、辛,微温。归肝、脾经。功效:活血化瘀,行水消肿。用于月经不调,经闭,痛经,产后瘀血腹痛,水肿。《日华子本草》中记载:通九窍,利关脉,养血气,破宿血,消症瘕,
益母草:为唇形科植物益母草Leonurus japonicus Houtt. 的新鲜或干燥地上部分。性味:苦、辛,微寒。归肝、心包经。功效:活血调经,利尿消肿。用于月经不调,痛经,经闭,恶露不尽,水肿尿少;急性肾炎水肿。
萹蓄:为蓼科植物萹蓄 Polygonum aviculare L. 的干燥地上部分。性味:苦,微寒。归膀胱经。功效:利尿通淋,杀虫,止痒。用于膀胱热淋,小便短赤,淋沥涩痛,皮肤湿疹,阴痒带下。《本经》中记载:主浸淫,疥瘙疽痔,杀三虫。
萆薢:为薯蓣科植物粉背薯蓣、叉蕊薯蓣、山萆薢或纤细薯蓣等的块茎。性味:苦,平。归肝、胃、膀胱经。功效:祛风,利湿。治风湿顽痹,腰膝疼痛,小便不利,淋浊,遗精,湿热疮毒。
川芎:为伞形科植物川芎Ligusticum chuanxiong Hort.(或Ligusticum wallichii Franch.)的干燥根茎。性味:辛,温。归肝、胆、心包经。功效:活血行气,祛风止痛。用于月经不调,经闭痛经,症瘕腹痛,胸胁刺痛,跌扑肿痛,头痛,风湿痹痛。《日华子本草》中记载:治一切风,一切气,一切劳损,一切血,补五劳,壮筋骨,调众脉,破癥结宿血,养新血,长肉,鼻洪,吐血及溺血,痔瘘,脑痈发背,瘰疬瘿赘,疮疥,及排脓消瘀血。
牛膝:为苋科植物牛膝Achyranthes bidentata Blume. 的干燥根。性味:苦、酸,平。归肝、肾经。功效:补肝肾,强筋骨,逐瘀通经,引血下行。用于腰膝酸痛,筋骨无力,经闭症瘕,肝阳眩晕。《日华子本草》中记载:治腰膝软怯冷弱,破癥结,排脓止痛,产后心腹痛并血运,落胎,壮阳。
当归:为伞形科植物当归Angelica sinensis (Oliv.) Diels 的干燥根。性味:甘、辛,温。归肝、心、脾经。功效:补血活血,调经止痛,润肠通便。用于血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,肠燥便秘,风湿痹痛,跌扑损伤,痈疽疮疡。酒当归活血通经。用于经闭痛经,风湿痹痛,跌扑损伤。《日华子本草》中记载:治一切风,一切血,补一切劳,破恶血,养新血及主癥癖。
红花:为菊科植物红花Carthamus tinctorius L.的干燥花。性味:辛,温。归心、肝经。功效:活血通经,散瘀止痛。用于经闭,痛经,恶露不行,症瘕痞块,跌扑损伤,疮疡肿痛。《纲目》:活血,润燥,止痛,散肿,通经。
本发明的方解是:方中熟地黄益精填髓,山药补肾涩精,枸杞子滋补肝肾,山茱萸补益肝肾,肉苁蓉补肾益精,巴戟天、续断、桑寄生、淫羊藿、牛膝、杜仲均补肾强骨,以上十一味药作为方中君药,均归肾经,具有补肾强骨、益精填髓的作用。中医学认为,重症IgA 肾
病属于本虚标实、虚实夹杂的病情阶段,在发病初期多由于阴亏脾弱,加之风热、湿毒所致。病情迁延、反复发作,导致正气渐伤,肾阴不足,水不涵木,以致肝肾阴虚而引发本病。所以补肾强骨、益精填髓是治疗IgA肾病的基础,以上十一味药均为君药,首先从根本上补肾强骨、益精填髓,使病症得到根本的控制。茯苓利水渗湿、健脾宁心,泽兰行水消肿,益母草活血调经、利尿消肿,萹蓄利尿通淋,萆薢祛风利湿,川芎活血行气、祛风止痛,当归补血活血、调经止痛,红花活血通经、散瘀止痛,以上八味药为方中臣药,归肝经。外因为风寒湿邪侵袭,筋挛膜凝而引发本病。以上八味药作为臣药,一方面辅助君药补肾强骨、益精填髓;另一方面作为臣药具有祛风利湿、活血补血功效。黄芪补气固表、利尿托毒,党参补中益气、健脾益肺,炒白术健脾益气、燥湿利水,薏苡仁健脾渗湿,白扁豆健脾化湿,以上五味药,作为佐药,从病理上治疗引起IgA肾病的诱因,作为佐药既能促进君臣二药的补肾强骨、益精填髓的功效,又能反佐君臣二药促进机体祛风利湿、活血补血。此方诸药合用,君臣协力,臣佐共辅,具有补肾强骨、益精填髓、祛风利湿、活血补血的作用的功效,能够有效治疗IgA肾病。
本发明另一个重要特点是该中药制剂含有丰富的营养成分,富含氨基酸有17种以上,其中人体必需氨基酸有苏氨酸、缬氨酸、蛋氨酸、异亮氨酸、亮氨酸、赖氨酸和苯丙氨酸,含有人体必需的微量元素有铁、铬、铜、硼、锰、锶、和锌,另含钙、钾、镁、磷几种人体宏量元素。以上营养成分都是人体必需物质,能有效增强人体免疫力。
本发明药物原料用量是经发明人进行大量摸索总结得出的,各原料用量为在下述重量份范围都具有较好的疗效:黄芪28-32份、党参18-22份、熟地黄18-22份、炒白术22-26份、茯苓13-17份、山药13-17份、薏苡仁18-22份、白扁豆18-22份、枸杞子13-17份、山茱萸10-14份、肉苁蓉13-17份、巴戟天13-17份、杜仲16-20份、续断18-22份、桑寄生16-20份、淫羊藿13-17份、泽兰10-14份、益母草16-20份、萹蓄13-17份、萆薢13-17份、川芎10-14份、牛膝13-17份、当归16-20份、红花7-11份。
其中优选为:黄芪30份、党参20份、熟地黄20份、炒白术24份、茯苓15份、山药15份、薏苡仁20份、白扁豆20份、枸杞子15份、山茱萸12份、肉苁蓉15份、巴戟天15份、杜仲18份、续断20份、桑寄生18份、淫羊藿15份、泽兰12份、益母草18份、萹蓄15份、萆薢15份、川芎12份、牛膝15份、当归18份、红花9份。
一种用于IgA肾病的中药制剂的制备方法如下:
步骤一:按本发明重量份配比,取熟地黄、炒白术,粉碎,过120目筛,备用;
步骤二:按本发明重量配比,取黄芪、党参、茯苓、肉苁蓉、巴戟天、杜仲、续断、桑寄生、牛膝药材置于砂锅中,加入8倍体积的水,武火熬煮20-30分钟后,加入枸杞子、山茱萸、淫羊藿、泽兰、益母草、萹蓄、萆薢、川芎、当归、红花及分别用纱布包扎好的山药、薏苡仁、白扁豆武火熬煮10-20分钟,转文火熬煮30~40分钟得滤液,反复熬煮三次合并所得滤液,备用;
步骤三:将步骤二所得滤液和步骤一所得粉末混合,搅匀,将药汤进行浓缩加乙醇,放置沉淀,过滤,弃沉淀,滤液回收乙醇,将所得药液浓缩为75℃环境下相对密度1.15~1.20的稠膏,将稠膏风干粉碎,加入蜂蜜、防腐剂、润湿剂等,进行捶打、搓条、成丸,晾干,分装入袋,每袋含有效成分0.1g,既得本发明所述的治疗IgA肾病的丸剂。
本发明使用方法:取药剂,每次一袋,每天饭后温水送服。
本发明药物具有补肾强骨、益精填髓、祛风利湿、活血补血的作用,且止痛效果好,价格低廉,无毒副作用,使用方便,该中药制剂采用的方式治疗可以减少西药对患者身体的伤害,减轻患者的病痛,据对临床240例患者观察统计,使用本发明药物一个疗程总有效率82.5%,两个疗程总有效率95%。
具体实施方式
实施例一:黄芪30份、党参20份、熟地黄20份、炒白术24份、茯苓15份、山药15份、薏苡仁20份、白扁豆20份、枸杞子15份、山茱萸12份、肉苁蓉15份、巴戟天15份、杜仲18份、续断20份、桑寄生18份、淫羊藿15份、泽兰12份、益母草18份、萹蓄15份、萆薢15份、川芎12份、牛膝15份、当归18份、红花9份。
实施例二:黄芪31份、党参21份、熟地黄21份、炒白术24份、茯苓14份、山药14份、薏苡仁20份、白扁豆20份、枸杞子15份、山茱萸11份、肉苁蓉14份、巴戟天15份、杜仲19份、续断21份、桑寄生18份、淫羊藿16份、泽兰13份、益母草17份、萹蓄15份、萆薢15份、川芎12份、牛膝14份、当归17份、红花8份。
实施例三:黄芪32份、党参21份、熟地黄20份、炒白术22份、茯苓14份、山药16份、薏苡仁20份、白扁豆20份、枸杞子15份、山茱萸11份、肉苁蓉14份、巴戟天14份、杜仲18份、续断20份、桑寄生18份、淫羊藿14份、泽兰13份、益母草18份、萹蓄15份、萆薢14份、川芎12份、牛膝14份、当归18份、红花10份。
就下面是患者使用本发明药物的临床统计资料:
一、 一般资料
收治门诊患者240例,将患者随机分为观察组和对照组各120例,其中男性200例,女性40例,男女比例5:1,最大年龄60岁,最小年龄18岁,病程几月到几年不等。两组患者年龄、性别、病程等各项基本资料基本相同,差异无统计学意义(P>0.05)。
二、 诊断标准
1、泡沫尿( 尿蛋白伴或不伴镜下多形性红细胞尿) ;
2、腰酸、乏力、口干、目涩、手足心热,眼睑或足跗浮肿,夜尿多;
3、苔脉:脉细或细数,舌红、苔薄、舌体胖或边有齿痕。
三、治疗方法:
1、观察组按照本发明药物实施例一,称取原料药按发明实施方法治疗,取药剂,每次一袋,每天饭后温水送服,每天三次。7天为一个疗程。
2、对照组采用常规西药细胞毒药物治疗,7天为一疗程。
四、疗效评定标准:
1、治愈:尿沉渣镜检红细胞少于0.8 万/毫升或3 个/高倍视野,肾功能正常。
2、有效:尿沉渣镜检红细胞数较前减少25% -49%,肾功能正常。
3、无效:上述实验检查均无明显改善或反加重者。
五、治疗结果统计:
对照组结果统计
使用该中药制剂两个疗程两组患者的疗效对比情况
其中:总有效率=治愈率+有效率
通过对比两组患者的治疗总有效率可以发现观察组明显高于对照组,由此说明,本发明中药在治疗IgA肾病上具有良好的临床效果,能有效提高治疗的治愈率,效果显著,价格低廉,无不良反应和任何毒副作用,具有广阔的市场应用前景。
典型病例及疗效:
病例一、患者王某,男,31岁,青岛市人,2010年2月20日来我处就诊。诊断结果:泡沫尿,腰酸、口干、目涩、手足心热,眼睑或足跗浮肿,夜尿多,脉细,舌红,确诊为IgA肾病。采用本发明实施例一中所制制剂,以及所选的制备方法,在治疗二个疗程后,效果甚好,症状基本恢复。
病例二、患者李某,男,39岁,山东临沂人。2010年6月11日来我处就诊,经诊断症状如下:尿蛋白伴,腰酸、乏力、口干、手足心热,夜尿多,脉细,舌红,舌体胖,确诊为IgA肾病。采用本发明实施例一中所制制剂,以及所选的制备方法,在治疗二个疗程后,效果甚好,肾功能完全或基本恢复,电话随访半年未复发。
Claims (4)
1.一种用于IgA肾病中药制剂,其特征在于,该中药制剂是由以下重量份的药物制成:黄芪28-32份、党参18-22份、熟地黄18-22份、炒白术22-26份、茯苓13-17份、山药13-17份、薏苡仁18-22份、白扁豆18-22份、枸杞子13-17份、山茱萸10-14份、肉苁蓉13-17份、巴戟天13-17份、杜仲16-20份、续断18-22份、桑寄生16-20份、淫羊藿13-17份、泽兰10-14份、益母草16-20份、萹蓄13-17份、萆薢13-17份、川芎10-14份、牛膝13-17份、当归16-20份、红花7-11份。
2.根据权利要求1所述的用于IgA肾病的中药制剂,其特征在于,由以下重量份的药物制成:黄芪30份、党参20份、熟地黄20份、炒白术24份、茯苓15份、山药15份、薏苡仁20份、白扁豆20份、枸杞子15份、山茱萸12份、肉苁蓉15份、巴戟天15份、杜仲18份、续断20份、桑寄生18份、淫羊藿15份、泽兰12份、益母草18份、萹蓄15份、萆薢15份、川芎12份、牛膝15份、当归18份、红花9份。
3.根据权利要求1或2所述的用于IgA肾病的中药制剂,其特征在于:所述中药制剂为丸剂。
4.一种用于IgA肾病的中药制剂的制备方法,其特征在于,制备方法如下:步骤一:按本发明重量份配比,取熟地黄、炒白术,粉碎,过120目筛,备用;步骤二:按本发明重量配比,取黄芪、党参、茯苓、肉苁蓉、巴戟天、杜仲、续断、桑寄生、牛膝药材置于砂锅中,加入8倍体积的水,武火熬煮20-30分钟后,加入枸杞子、山茱萸、淫羊藿、泽兰、益母草、萹蓄、萆薢、川芎、当归、红花及分别用纱布包扎好的山药、薏苡仁、白扁豆武火熬煮10-20分钟,转文火熬煮30~40分钟得滤液,反复熬煮三次合并所得滤液,备用;步骤三:将步骤二所得滤液和步骤一所得粉末混合,搅匀,将药汤进行浓缩加乙醇,放置沉淀,过滤,弃沉淀,滤液回收乙醇,将所得药液浓缩为75℃环境下相对密度1.15~1.20的稠膏,将稠膏风干粉碎,加入蜂蜜、防腐剂、润湿剂等,进行捶打、搓条、成丸,晾干,分装入袋,每袋含有效成分0.1g,既得本发明所述的治疗IgA肾病的丸剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510323175.0A CN104922538A (zh) | 2015-06-15 | 2015-06-15 | 一种用于IgA肾病中药制剂及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510323175.0A CN104922538A (zh) | 2015-06-15 | 2015-06-15 | 一种用于IgA肾病中药制剂及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104922538A true CN104922538A (zh) | 2015-09-23 |
Family
ID=54110186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510323175.0A Pending CN104922538A (zh) | 2015-06-15 | 2015-06-15 | 一种用于IgA肾病中药制剂及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104922538A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105878837A (zh) * | 2016-05-30 | 2016-08-24 | 阜新市糖尿病医院 | 治疗肾病的中药 |
| CN107137480A (zh) * | 2017-06-12 | 2017-09-08 | 石家庄华夏肾病研究院 | 一种治疗IgA肾病的中药组合物及其使用方法 |
| US20170296607A1 (en) * | 2014-10-13 | 2017-10-19 | Korea Institute Of Oriental Medicine | Composition including extract of dolichos lablab linne as active ingredient for preventing or ameliorating non-alcoholic fatty liver disease |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060058384A1 (en) * | 2004-09-10 | 2006-03-16 | Pronova Biocare, A.S. | Treatment of IGA nephropathy with omega-3 fatty acids |
| CN104606486A (zh) * | 2015-01-04 | 2015-05-13 | 上海中医药大学附属龙华医院 | 一种治疗IgA肾病的中药组合物及其应用 |
-
2015
- 2015-06-15 CN CN201510323175.0A patent/CN104922538A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060058384A1 (en) * | 2004-09-10 | 2006-03-16 | Pronova Biocare, A.S. | Treatment of IGA nephropathy with omega-3 fatty acids |
| CN104606486A (zh) * | 2015-01-04 | 2015-05-13 | 上海中医药大学附属龙华医院 | 一种治疗IgA肾病的中药组合物及其应用 |
Non-Patent Citations (1)
| Title |
|---|
| 魏晓娜等: "中西医结合治疗难治性肾病综合征60例", 《河北中医》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170296607A1 (en) * | 2014-10-13 | 2017-10-19 | Korea Institute Of Oriental Medicine | Composition including extract of dolichos lablab linne as active ingredient for preventing or ameliorating non-alcoholic fatty liver disease |
| US10617732B2 (en) * | 2014-10-13 | 2020-04-14 | Korea Institute Of Oriental Medicine | Composition including extract of Dolichos lablab Linne as active ingredient for preventing or ameliorating non-alcoholic fatty liver disease |
| CN105878837A (zh) * | 2016-05-30 | 2016-08-24 | 阜新市糖尿病医院 | 治疗肾病的中药 |
| CN105878837B (zh) * | 2016-05-30 | 2019-08-16 | 阜新市糖尿病医院 | 治疗肾病的中药 |
| CN107137480A (zh) * | 2017-06-12 | 2017-09-08 | 石家庄华夏肾病研究院 | 一种治疗IgA肾病的中药组合物及其使用方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104352776B (zh) | 一种治疗月经过少致不孕的中药制剂及其制备方法 | |
| CN108014289A (zh) | 用于调理阳虚体质的中药膏方及其加工方法 | |
| CN106075276A (zh) | 一种用于治疗先兆流产的中药制剂及其制备方法 | |
| CN104958701A (zh) | 一种用于高泌乳素血症的中药制剂及其制备方法 | |
| CN104825963A (zh) | 一种用于习惯性流产的中药制剂及其制备方法 | |
| CN104784648A (zh) | 一种用于厌食症的中药制剂及其制备方法 | |
| CN104740437A (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
| CN105876710A (zh) | 一种抗衰老富硒紫玉淮山龟苓膏及其制备方法 | |
| CN104857455A (zh) | 一种用于慢性间质性肾病中药制剂及其制备方法 | |
| CN104800771A (zh) | 一种用于儿童夜惊症的中药制剂及其制备方法 | |
| CN104826074A (zh) | 一种用于窦性心动过缓的中药制剂及其制备方法 | |
| CN104840891A (zh) | 一种用于酒精性心肌病的中药制剂及其制备方法 | |
| CN104888042A (zh) | 一种用于产后恶露不绝病的中药制剂及其制备方法 | |
| CN103417893B (zh) | 一种治疗腰腿痛的药物及其制备方法 | |
| CN106362120A (zh) | 一种治疗高血糖和糖尿病的中药方剂 | |
| CN105435131A (zh) | 一种治疗慢性心衰的中药组合物及其制备方法 | |
| CN104906526A (zh) | 一种用于卵巢早衰的中药制剂及其制备方法 | |
| CN104906511A (zh) | 一种用于反流性食管炎中药制剂及其制备方法 | |
| CN104435962A (zh) | 用于治疗仔猪消化不良性下痢的药物组合物及其制备方法 | |
| CN101274061A (zh) | 一种滋阴胶囊组配方法及制作工艺 | |
| CN104873854A (zh) | 一种用于小动脉性肾硬化症的中药制剂及其制备方法 | |
| CN105999019A (zh) | 一种用于增强乳腺癌化疗疗效的中药制剂及其制备方法 | |
| CN104825909A (zh) | 一种用于肾癌的中药制剂及其制备方法 | |
| CN105288492A (zh) | 一种用于直肠癌的中药制剂及其制备方法 | |
| CN105194547A (zh) | 一种用于嗜酸性筋膜炎的中药制剂及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150923 |
|
| WD01 | Invention patent application deemed withdrawn after publication |